Diabetes Technology & Therapeutics
Journal
Overview
publication venue for
A comparison of continuous glucose monitoring-measured time-in-range 70-180 mg/dL versus time-in-tight-range 70-140 mg/dL
2024
A scalable application of artificial intelligence-driven insulin titration program to transform type 2 diabetes management
2024
Continuous glucose monitoring metrics and hemoglobin A1c relationship in patients with type 2 diabetes treated by hemodialysis
2024
Continuous glucose monitoring prediction of gestational diabetes mellitus and perinatal complications
2024
Expert panel recommendations for a standardized ambulatory glucose profile report for connected insulin pens
2024
Glycemic outcomes persist for up to 2 years in very young children with the Omnipod(®) 5 Automated Insulin Delivery System
2024
Time in range, time in tight range, and average glucose relationships are modulated by glycemic variability: identification of a glucose distribution model connecting glycemic parameters using real-world data
2024
Two years with a tubeless automated insulin delivery system: a single-arm multicenter trial in children, adolescents, and adults with Type 1 diabetes
2024
A comparison of continuous glucose monitoring estimated hemoglobin A1c in adults with type 1 or type 2 diabetes
2023
Assessment of the glucose management indicator using different sampling durations
2023
Discordance between glucose management indicator and glycated hemoglobin in people without diabetes
2023
Improved glycemia with hybrid closed-loop versus continuous subcutaneous insulin infusion therapy: results from a randomized controlled trial
2023
Increased derived time in range is associated with reduced risk of major adverse cardiovascular events, severe hypoglycemia, and microvascular events in type 2 diabetes: a post hoc analysis of DEVOTE
2023
Safety and glycemic outcomes during the MiniMed(TM) advanced hybrid closed-loop system pivotal trial in children and adolescents with type 1 diabetes
2023
The relationship between percent time <70 mg/dL and percent time <54 mg/dL measured by continuous glucose monitoring
2023
A comparison of postprandial glucose control in the Medtronic advanced hybrid closed-loop system versus 670G
2022
Benefit of continuous glucose monitoring in reducing hypoglycemia is sustained through 12 months of use among older adults with type 1 diabetes
2022
Impact of temporary glycemic target use in the hybrid and advanced hybrid closed-loop systems
2022
Real-world evidence supporting Tandem Control-IQ Hybrid Closed-Loop success in the Medicare and Medicaid type 1 and type 2 diabetes populations
2022
Safety and glycemic outcomes during the MiniMed™ Advanced Hybrid Closed-Loop System Pivotal Trial in adolescents and adults with type 1 diabetes
2022
The optimal duration of a run-in period to initiate continuous glucose monitoring for a randomized trial
2022
Continuous glucose monitoring integration for remote diabetes management: virtual diabetes care with case studies
2021
First outpatient evaluation of a tubeless automated insulin delivery system with customizable glucose targets in children and adults with type 1 diabetes
2021
Lived experience of advanced hybrid closed-loop versus hybrid closed-loop: patient-reported outcomes and perspectives
2021
Lost in translation: a disconnect between the science and Medicare coverage criteria for continuous subcutaneous insulin infusion
2021
Real-world, patient-reported and clinic data from individuals with type 1 diabetes using the MiniMed 670G hybrid closed-loop system
2021
Remote application and use of real-time continuous glucose monitoring by adults with type 2 diabetes in a virtual diabetes clinic
2021
The digital/virtual diabetes clinic: the future Is now-recommendations from an international panel on diabetes digital technologies introduction
2021
Ultrarapid lispro demonstrates similar time in target range to lispro with a hybrid closed-loop system
2021
Ultra-rapid lispro improves postprandial glucose control and time in range in type 1 diabetes compared to lispro: PRONTO-T1D Continuous Glucose Monitoring Substudy
2020
Current status and future directions for electronic point-of-care clinical decision support to improve diabetes management in primary care
2019
Implementation of basal-bolus therapy in type 2 diabetes: a randomized controlled trial comparing bolus insulin delivery using an insulin patch with an insulin pen
2019
Rationale and design for a GRADE substudy of continuous glucose monitoring
2019
State of type 1 diabetes management and outcomes from the T1D Exchange in 2016-2018
2019
The association of biochemical hypoglycemia with the subsequent risk of a severe hypoglycemic event: analysis of the DCCT data set
2019
Optimal sampling duration for continuous glucose monitoring to determine long-term glycemic control
2018
Glucose outcomes with the in-home use of a hybrid closed-loop insulin delivery system in adolescents and adults with type 1 diabetes
2017
Efficacy and safety of flexible versus fixed dosing intervals of insulin glargine 300 U/mL in people with type 2 diabetes
2016
Hypoglycemia in older adults with type 1 diabetes
2016
Recommendations for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: the Ambulatory Glucose Profile (AGP)
2013
Advanced meter features improve postprandial and paired self-monitoring of blood glucose in individuals with diabetes: results of the Actions with the CONTOUR Blood Glucose Meter and Behaviors in Frequent Testers (ACT) study
2012
Can a tool that automates insulin titration be a key to diabetes management?
2012
Health-related quality of life and treatment satisfaction in the Sensor-Augmented Pump Therapy for A1C Reduction 3 (STAR 3) trial
2012
Baseline predictors of A1C reduction in adults using sensor-augmented pump therapy or multiple daily injection therapy: the STAR 3 experience
2011
Comparison of a novel insulin bolus-patch with pen/syringe injection to deliver mealtime insulin for efficacy, preference, and quality of life in adults with diabetes: a randomized, crossover, multicenter study
2011
International Forum for the Advancement of Diabetes Research and Care, April 29-30, 2011, Athens, Greece
2011
A comparison between simplified and intensive dose-titration algorithms using AIR inhaled insulin for insulin-naive patients with type 2 diabetes in a randomized noninferiority trial
2009
Detection of hypoglycemia with continuous interstitial and traditional blood glucose monitoring using the FreeStyle Navigator Continuous Glucose Monitoring System
2009
Does availability of AIR insulin increase insulin use and improve glycemic control in patients with type 2 diabetes?
2009
Evaluating the accuracy, reliability, and clinical applicability of continuous glucose monitoring (CGM): is CGM ready for real time?
2009
Self-Monitoring of Blood Glucose (SMBG) Applications and Beyond, 2nd Annual Symposium, May 7-10, 2009, Berlin, Germany
2009
Characterizing glucose exposure for individuals with normal glucose tolerance using continuous glucose monitoring and ambulatory glucose profile analysis
2008
Impact of modem-transferred blood glucose data on clinician work efficiency and patient glycemic control
2005
Making sense of glucose monitoring technologies: from SMBG to CGM
2005
Novel pattern identification through standardized data display using the ambulatory glucose profile (AGP) report [abstract]
2016
Continuous glucose monitoring for type 2 diabetes: how does it compare with type 1 diabetes [editorial]?.
24.
2022
Decreasing the burden of carbohydrate counting and meal announcement with automated insulin delivery, meal recognition, and autocorrection doses: a case study [review]
2024
Is it time to move beyond TIR to TITR? Real-world data from over 20,000 users of continuous glucose monitoring in patients with type 1 and type 2 diabetes [review]
2024
Primary care and diabetes technologies and treatments [review]
2024
Coverage for continuous glucose monitoring for individuals with type 2 diabetes treated with nonintensive therapies: an evidence-based approach to policymaking [review]
2023
Personalized glycated hemoglobin in diabetes management: closing the gap with glucose management indicator [review]
2023
Prevalence, cost, and burden of diabetic ketoacidosis [review]
2023
Primary care and diabetes technologies and treatments [review]
2023
Primary care and diabetes technologies and treatments [review]
2022
Comparison of second-generation basal insulin analogs: a review of the evidence from continuous glucose monitoring [review]
2021
Primary care and diabetes technologies and treatments [review]
2021
What's wrong with this picture? A critical review of current Centers for Medicare & Medicaid Services coverage criteria for continuous glucose monitoring [review]
2021
Utilizing the ambulatory glucose profile to standardize and implement continuous glucose monitoring in clinical practice [review]
2019
Clinical use of continuous glucose monitoring in adults with type 2 diabetes [review]
2017
Role of continuous glucose monitoring in clinical trials: recommendations on reporting [review]
2017
Clinical application of emerging sensor technologies in diabetes management: consensus guidelines for continuous glucose monitoring (CGM) [review]
2008